Variability of persisting MHV RNA sequences constituting immune and replication-relevant domains

Virology

Volumn 244, Issue 2, 1998, Pages 563-572

  Bergmann, Cornelia ^a   DiMacAli, Emmanuel ^a   Stohl, Sheldon ^a   Wei, Wen ^a   Lai, Michael M C ^a   Tahara, Stanley ^a   Marten, Norman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; GENE MUTATION; GENE SEQUENCE; IMMUNE RESPONSE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS GENOME; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0032503248     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9147     Document Type: Article

References (50)

1. Adami C., Pooley J., Glomb J., Stecker E., Fazal F., Fleming J. O., Baker S. C. Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA. Virology. 209:1995;337-346.
2. b. J. Gen. Virol. 77:1996;315-325.
3. d. J. Virol. 70:1996;3252-3257.
4. d. J. Virol. 67:1993a;7041-7049.
5. Bergmann C., Stohlman S. A., McMillan M. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur. J. Immunol. 23:1993b;2777-2781.
6. +. J. Virol. 69:1995;8127-8131.
7. Chen W., Baric R. S. Molecular anatomy of mouse hepatitis virus persistence: Coevolution of increased host cell resistance and virus virulence. J. Virol. 70:1996;3947-3960.
8. Chen W., Baric R. S. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:1995;7529-7540.
9. Cheynier R., Henrichwark S., Hadida F., Pelletier E., Oksenhendler E., Autran B., Wain-Hobson S. Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replicationin situ. Adv. Exp. Med. Biol. 374:1995;173-182.
10. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119:1982;358-371.
11. d. J. Exp. Med. 176:1992;1681-1692.
12. Cua D., Hinton D., Stohlman S. A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J. Immunol. 155:1995;4052-4059.
13. Dveksler G. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G. S., Holmes K. V., Dieffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
14. Erlich S. S., Fleming J. O., Stohlman S. A., Weiner L. P. Experimental neuropathology of chronic demyelination induced by JHM virus variant DS. Arch. Neurol. 44:1987;839-842.
15. Fazakerley J. K., Buchmeier M. J. Pathogenesis of virus-induced demyelination. Adv. Virus Res. 42:1993;249-324.
16. Fleming J. O., Houtman J. J., Alaca H., Hinze H. C., McKenzie D., Aiken J., Bleasdale T., Baker S. Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. Adv. Exp. Biol. Med. 342:1994;327-332.
17. Fleming J. O., Trousdale M. D., El-Zaatari F. A. K., Stohlman S. A., Weiner L. P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. Virology. 58:1986;869-875.
18. +. Eur. J. Immunol. 23:1993;1757-1761.
19. Fosmire J. A., Hwang K., Makino S. Identification and characterization of a coronavirus packaging signal. J. Virol. 66:1992;3522-3530.
20. Frana M. F., Behnke J. N., Sturman L. S., Holmes K. V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:1985;912-920.
21. Gombold J. L., Thingley S. T., Weiss S. R. Fusion-negative mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:1993;1916-1928.
22. Hahn S. C., Hahn Y. S., Braciale T. J., Rice C. M. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA. 89:1992;2679-2683.
23. Hofacker I. L., Fontana W., Stadler P. F., Bonhoeffer L. S., Tacker M., Schuster P. Fast folding and comparisons of RNA secondary structure. Monatshefte Chemie. 125:1994;167-188.
24. Houtman J. J., Fleming J. O. Pathogenesis of mouse hepatitis virus-induced demyelination. J. NeuroVirol. 2:1996;361-376.
25. Klenerman P., Phillips R., McMichael A. Cytotoxic T-cell antagonism in HIV-1. Semin. Virol. 7:1996;31-39.
26. Kyuwa S., Stohlman S. A. Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Semin. Virol. 1:1990;273-280.
27. Lai M., Cavanagh D. Molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
28. Lane T. E., Buchmeier M. J. Murine coronavirus infection: A paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:1997;9-14.
29. Murphy E., Hieny S., Sher A., O'Garra A. Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method inSchistosoma mansoni. J. Immunol. Methods. 162:1993;211-223.
30. Ossendorp F., Eggers M., Neisig A., Ruppert T., Groettrup M., Sijts A., Mengede E., Kloetzel P-M., Neefjes J., Koszinowski U., Melief C. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:1996;115-124.
31. Parker S. E., Gallagher T. M., Buchmeier M. J. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitus virus. Virology. 173:1989;664-673.
32. Parker M. M., Masters P. S. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure of the nucleocapsid protein. Virology. 179:1990;463-468.
33. Perlman S, Schelper R., Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microbial Pathog. 2:1987;185-194.
34. Pewe L., Shurong X., Perlman S. Cytotoxic T-cell resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. J. Virol. 71:1997;7640-7647.
35. Pewe L., Wu G. F., Barnett E. M., Castro R. F., Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 5:1996;253-262.
36. Pfleiderer M., Skinner M. A., Siddell S. K. Coronavirus MHV-JHM: Nucleotide sequence of the mRNA that encodes the membrane protein. Nucleic Acids Res. 14:1986;6338.
37. Rottier P. J., Welling G. E., Welling-Webster S., Niesters H. G., Lenstra J. A., van der Zeijst B. A. M. Predicted membrane topology of the coronavirus protein E1. Biochemistry. 25:1986;1335-1339.
38. Rowe C. L., Baker S. C., Nathan M. J., Fleming J. O. Evolution of mouse hepatitis virus: Detection and characterization of spike deletion variants during persistent infection. J. Virol. 71:1997a;2959-2969.
39. Rowe C. L., Fleming J. O., Nathan M. J., Sgro J.-Y., Palmenberg A. C., Baker S. C. Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J. Virol. 71:1997b;6183-6190.
40. Skinner M. A., Sidell S. G. Coronavirus JHM: nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res. 11:1983;5045-5054.
41. Smith D. B., McAllister J., Casino C., Simmonds P. Virus 'quasispecies': making a mountain out of a molehill. J. Gen. Virol. 78:1997;1511-1519.
42. Stohlman S. A., Bergmann C., van der Veen R., Hinton D. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous sytem. J. Virol. 69:1995;684-694.
43. Stohlman S. A., Bergmann C., Cua D., Wege H., van der Veen R. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology. 202:1994;146-153.
44. Stohlman S., Kyuwa S., Polo J., Brady D., Spaan W., Lai M., Bergmann C. Characterization of Mouse Hepatitis Virus specific T cells derived from the central nervous system of JHM virus infected mice. J. Virol. 67:1993;7050-7059.
45. Stohlman S. A., Brayton P. R., Fleming J. O., Weiner L. P., Lai M. M. C. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 63:1982;265-275.
46. Stohlman S. A., Fleming J. O., Patton C. D., Lai M. M. CM. M. Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virol. 130:1983;527-532.
47. +. Virol. 225:1996;330-346.
48. Wege H., Winter J., Meyermann R. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: Definition of critical epitopes by variant analysis. J. Gen Virol. 69:1988;87-98.
49. ++. J. Virol. 64:1990;45890-44592.
50. Yokomori K., Lai M. M. C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:1992;6194-6199.